188 related articles for article (PubMed ID: 37219825)
1. Choice of anticoagulation in patients with low risk antiphospholipid syndrome.
Bakow BR; Phung Q; Rabinovich D; Olszewski AJ; Reagan JL
J Thromb Thrombolysis; 2023 Jul; 56(1):121-127. PubMed ID: 37219825
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
[TBL] [Abstract][Full Text] [Related]
3. Direct oral anticoagulants versus warfarin in patients with antiphospholipid syndrome: A meta-analysis of randomized controlled trials.
Lee YH; Song GG
Lupus; 2022 Oct; 31(11):1335-1343. PubMed ID: 35968627
[TBL] [Abstract][Full Text] [Related]
4. Use of direct oral anticoagulants in antiphospholipid syndrome.
Cohen H; Efthymiou M; Isenberg DA
J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
[TBL] [Abstract][Full Text] [Related]
5. Cessation of oral anticoagulants in antiphospholipid syndrome.
Comarmond C; Jego P; Veyssier-Belot C; Marie I; Mekinian A; Elmaleh-Sachs A; Leroux G; Saadoun D; Oziol E; Fraisse T; Hyvernat H; Thiercein-Legrand MF; Sarrot-Reynauld F; Ferreira-Maldent N; de Menthon M; Goujard C; Khau D; Nguen Y; Monnier S; Michon A; Castel B; Decaux O; Piette JC; Cacoub P
Lupus; 2017 Oct; 26(12):1291-1296. PubMed ID: 28355985
[TBL] [Abstract][Full Text] [Related]
6. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.
Dufrost V; Risse J; Zuily S; Wahl D
Curr Rheumatol Rep; 2016 Dec; 18(12):74. PubMed ID: 27812956
[TBL] [Abstract][Full Text] [Related]
7. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.
Dufrost V; Wahl D; Zuily S
Autoimmun Rev; 2021 Jan; 20(1):102711. PubMed ID: 33197580
[TBL] [Abstract][Full Text] [Related]
8. Direct oral anticoagulants versus warfarin in patients with single antibody-positive anti-phospholipid syndrome.
Liu A; Rupani KV; Naymagon L
Eur J Haematol; 2022 Jul; 109(1):69-74. PubMed ID: 35305281
[TBL] [Abstract][Full Text] [Related]
9. Low recurrent thrombosis rates in single positive antiphospholipid syndrome regardless of type of anticoagulation.
Bakow BR; Yanek L; Crowther MA; Chaturvedi S
Thromb Res; 2024 May; 237():88-93. PubMed ID: 38569453
[TBL] [Abstract][Full Text] [Related]
10. Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis.
Wu X; Cao S; Yu B; He T
Blood Coagul Fibrinolysis; 2022 Oct; 33(7):389-401. PubMed ID: 35867933
[TBL] [Abstract][Full Text] [Related]
11. Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome.
Williams B; Saseen JJ; Trujillo T; Palkimas S
J Thromb Thrombolysis; 2022 Jul; 54(1):67-73. PubMed ID: 34817786
[TBL] [Abstract][Full Text] [Related]
12. Direct oral anticoagulants in antiphospholipid syndrome: a real life case series.
Betancur JF; Bonilla-Abadía F; Hormaza AA; Jaramillo FJ; Cañas CA; Tobón GJ
Lupus; 2016 May; 25(6):658-62. PubMed ID: 26743321
[TBL] [Abstract][Full Text] [Related]
13. Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis.
Sanchez-Redondo J; Espinosa G; Varillas Delgado D; Cervera R
Clin Ther; 2019 Sep; 41(9):1839-1862. PubMed ID: 31405527
[TBL] [Abstract][Full Text] [Related]
14. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.
Ruiz-Irastorza G; Khamashta MA; Hunt BJ; Escudero A; Cuadrado MJ; Hughes GR
Arch Intern Med; 2002 May; 162(10):1164-9. PubMed ID: 12020188
[TBL] [Abstract][Full Text] [Related]
15. Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS).
Woller SC; Stevens SM; Kaplan DA; Branch DW; Aston VT; Wilson EL; Gallo HM; Johnson EG; Rondina MT; Lloyd JF; Evans RS; Elliott CG
Clin Appl Thromb Hemost; 2016 Apr; 22(3):239-47. PubMed ID: 26566669
[TBL] [Abstract][Full Text] [Related]
16. Direct oral anticoagulants in patients with antiphospholipid syndrome: a retrospective study in a real-life patient cohort.
Franke B; Luxembourg B; Heidinger K; Kemkes-Matthes B; Sachs UJ
Blood Coagul Fibrinolysis; 2022 Apr; 33(3):184-187. PubMed ID: 33587483
[TBL] [Abstract][Full Text] [Related]
17. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
Malec K; Góralczyk T; Undas A
Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis.
Dufrost V; Risse J; Reshetnyak T; Satybaldyeva M; Du Y; Yan XX; Salta S; Gerotziafas G; Jing ZC; Elalamy I; Wahl D; Zuily S
Autoimmun Rev; 2018 Oct; 17(10):1011-1021. PubMed ID: 30103045
[TBL] [Abstract][Full Text] [Related]
19. Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
Resseguier AS; Pereira B; Rieu V; Le Guenno G; Grobost V; Ruivard M
Lupus; 2017 Oct; 26(12):1297-1303. PubMed ID: 28355988
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of the direct oral anticoagulants in non-triple positive antiphospholipid syndrome without prior arterial thromboembolism.
Kwan V; Kaplovitch E; Selby R; Abdulrehman J
J Thromb Thrombolysis; 2022 Apr; 53(3):690-696. PubMed ID: 34613576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
